Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
Henricus A.M. Mutsaers, Rikke Nørregaard
Kidney Res Clin Pract. 2022;41(1):4-13.   Published online 2022 Jan 13     DOI: https://doi.org/10.23876/j.krcp.21.222
Citations to this article as recorded by Crossref logo
EP 1 receptor antagonism mitigates early and late stage renal fibrosis
Jean‐Claude Kresse, Henricus A. M. Mutsaers, Michael Schou Jensen, Stine Julie Tingskov, Mia Gebauer Madsen, Lene N. Nejsum, Helle Prætorius, Rikke Nørregaard
Acta Physiologica.2022;[Epub]     CrossRef
Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
Xu Guan, Yong Liu, Wang Xin, Shaozong Qin, Shuiqin Gong, Tangli Xiao, Daohai Zhang, Yan Li, Jiachuan Xiong, Ke Yang, Ting He, Jinghong Zhao, Yinghui Huang
Frontiers in Pharmacology.2022;[Epub]     CrossRef